Stay updated on LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.

Latest updates to the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page
- CheckyesterdayChange DetectedA new Revision: v3.6.5 entry was added to the version history, and the previous Revision: v3.6.4 entry was removed. This updates the history to reflect the latest site revision.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry v3.6.4 appears in the history, replacing the previous v3.6.3, indicating a minor update to the page’s version.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag updated to v3.6.3 on the Study Record History page, replacing the previous v3.6.2. This indicates a minor page revision in the site's revision history interface.SummaryDifference0.1%

- Check44 days agoChange DetectedA new revision entry v3.6.2 appears in the record history, replacing v3.6.0. This marks a minor platform/format update to the page's history display with no changes to the study data or trial details.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history now shows recruitment is closed (no longer looking for participants). The revision note was updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check65 days agoChange DetectedA new revision tag, v3.5.5, has been added to the record history, replacing the previous v3.5.4. This indicates an update to the page's revision documentation without altering study data or content.SummaryDifference0.1%

Stay in the know with updates to LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LGX818/MEK162 vs Vemurafenib/LGX818 in Melanoma Clinical Trial page.